We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+38.57%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$680B
AUM Growth
+$89.5B
Cap. Flow
-$28.8B
Cap. Flow %
-4.24%
Top 10 Hldgs %
21.1%
Holding
2,615
New
56
Increased
1,632
Reduced
714
Closed
86

Sector Composition

Rank Sector Weight
1 Technology 19.47%
2 Healthcare 18.48%
3 Consumer Discretionary 13.66%
4 Financials 13.47%
5 Communication Services 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STAY
1351
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$7.58M ﹤0.01%
422,337
+29,234
+7% +$508K
UA icon
1352
Under Armour Class C
UA
$2.26B
$7.41M ﹤0.01%
392,404
MAN icon
1353
ManpowerGroup
MAN
$2.72B
$7.3M ﹤0.01%
88,314
-3,384
-4% -$267K
SYNA icon
1354
Synaptics
SYNA
$4.23B
$7.22M ﹤0.01%
181,657
-32,896
-15% -$1.3M
NLY icon
1355
Annaly Capital Management
NLY
$17.6B
$7.2M ﹤0.01%
180,145
+12,346
+7% +$504K
STRT icon
1356
STRATTEC Security
STRT
$347M
$7.19M ﹤0.01%
244,761
EDIT icon
1357
Editas Medicine
EDIT
$428M
$7.04M ﹤0.01%
287,826
-237,063
-45% -$5.37M
UAA icon
1358
Under Armour
UAA
$2.31B
$6.97M ﹤0.01%
329,502
CMO
1359
DELISTED
Capstead Mortgage Corp.
CMO
$6.94M ﹤0.01%
807,617
+775,974
+2,452% +$6.08M
FBRX icon
1360
Forte Biosciences
FBRX
$1.57B
$6.85M ﹤0.01%
1,680
-181
-10% -$699K
NPTN
1361
DELISTED
NEOPHOTONICS CORP
NPTN
$6.81M ﹤0.01%
+1,083,293
New +$7.59M
CHRS icon
1362
Coherus Oncology
CHRS
$182M
$6.74M ﹤0.01%
494,219
-329,442
-40% -$4.4M
SAND
1363
DELISTED
Sandstorm Gold
SAND
$6.62M ﹤0.01%
1,213,827
+819,703
+208% +$4.33M
IMGN
1364
DELISTED
Immunogen Inc
IMGN
$6.61M ﹤0.01%
2,440,764
+103,471
+4% +$448K
TRGP icon
1365
Targa Resources
TRGP
$59.2B
$6.57M ﹤0.01%
158,159
+25,080
+19% +$1.05M
MUB icon
1366
iShares National Muni Bond ETF
MUB
$45.8B
$6.56M ﹤0.01%
59,028
+36,198
+159% +$3.97M
FDC
1367
DELISTED
First Data Corporation
FDC
$6.56M ﹤0.01%
249,606
+1,930
+0.8% +$45.8K
WOLF icon
1368
Wolfspeed
WOLF
$1.61B
$6.53M ﹤0.01%
114,132
+431
+0.4% +$22.1K
NEWR
1369
DELISTED
New Relic, Inc.
NEWR
$6.52M ﹤0.01%
66,039
+719
+1% +$71.2K
PRQR icon
1370
ProQR Therapeutics
PRQR
$261M
$6.43M ﹤0.01%
463,425
-17,000
-4% -$254K
HRTG icon
1371
Heritage Insurance Holdings
HRTG
$1B
$6.41M ﹤0.01%
439,276
+366
+0.1% +$5.41K
IRTC icon
1372
iRhythm Holdings
IRTC
$4.16B
$6.36M ﹤0.01%
84,792
UBA
1373
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$6.22M ﹤0.01%
301,339
-787,843
-72% -$16.4M
PHAS
1374
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$6.2M ﹤0.01%
651,701
+600
+0.1% +$2.38K
NTUS
1375
DELISTED
Natus Medical Inc
NTUS
$6.18M ﹤0.01%
243,495
-113,146
-32% -$3.38M

Similar funds

T. Rowe Price Associates's Q1 2019 Portfolio in Review

As of Q1 2019, T. Rowe Price Associates held 2,615 positions worth $680B, up 15% from $591B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

T. Rowe Price Associates withdrew a net $28.8B in Q1 2019, closing 86 positions and reducing 714 holdings. Its most notable exit was Twenty-First Century Fox, Inc. Class B, an estimated $1.55B position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Associates opened a new position in Fox Class B worth $420M.

  • T. Rowe Price Associates's largest Q1 2019 buy was Fox Class B: 11,707,204 shares worth $420M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q1 2019, an estimated $2.84B increase.
  • T. Rowe Price Associates's biggest Q1 2019 reduction was TotalEnergies, cutting an estimated $25.3B.
  • T. Rowe Price Associates fully exited Twenty-First Century Fox, Inc. Class B in Q1 2019, selling an estimated $1.55B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $680B portfolio in Q1 2019.
  • T. Rowe Price Associates opened 56 new positions and closed 86 in Q1 2019.
  • T. Rowe Price Associates's portfolio value rose 15% quarter-over-quarter to $680B.

Based on T. Rowe Price Associates's 13F filing for Q1 2019, filed 15 May 2019.